|
TEX264 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.099640E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.935600E-03 |
| Normal-vs-Stage2 |
5.495600E-02 |
| Normal-vs-Stage3 |
2.199600E-03 |
| Normal-vs-Stage4 |
3.403700E-03 |
| Stage1-vs-Stage2 |
3.636300E-04 |
| Stage1-vs-Stage3 |
2.764800E-01 |
| Stage1-vs-Stage4 |
2.339400E-01 |
| Stage2-vs-Stage3 |
7.85550000000912E-05 |
| Stage2-vs-Stage4 |
1.242580E-04 |
| Stage3-vs-Stage4 |
7.102800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.201300E-04 |
| Normal-vs-AfricanAmerican |
5.337400E-03 |
| Normal-vs-Asian |
1.135380E-01 |
| Caucasian-vs-AfricanAmerican |
4.380800E-01 |
| Caucasian-vs-Asian |
3.545200E-01 |
| AfricanAmerican-vs-Asian |
1.960750E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.820230E-01 |
| Normal-vs-Female |
5.180600E-03 |
| Male-vs-Female |
1.744780E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.044200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.985880E-02 |
| Normal-vs-Age(61-80Yrs) |
3.333800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.744000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.767000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.167350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.087600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.788400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.232600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.361400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.39109999999876E-05 |
| Classical-VS-Follicular |
5.1272996959284E-10 |
| Classical-VS-Other |
3.407600E-01 |
| Classical-VS-Normal |
4.448600E-04 |
| Tall-VS-Follicular |
3.66373598126302E-15 |
| Tall-VS-Other |
9.514000E-02 |
| Tall-VS-Normal |
4.60040006089457E-10 |
| Follicular-VS-Other |
1.944760E-01 |
| Follicular-VS-Normal |
1.189520E-02 |
| Other-VS-Normal |
6.126000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.365000E-01 |
| Normal-vs-N1 |
5.591600E-04 |
| N0-vs-N1 |
1.240420E-03 |
|
|
